Global Ovarian Cancer Drugs Market
According to Intent Market Research, the Ovarian Cancer Drugs Market is expected to grow from USD 4.2 Billion in 2024-e at a CAGR of 10.7% to touch USD 8.5 Billion by 2030. The Ovarian Cancer Drugs Market is dominated by key players such as, AstraZeneca PLC, Merck & Co., Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Roche Holding AG, and Pfizer Inc.